7.36  0.66 (9.85%)		01-14 00:00
Open: 6.29 High: 12.22 Volume: 1,532,334		Pre. Close: 9.73 Low: 9.8 Market Cap: 540(M)

Short term
Mid term
Targets	6-month :	11.53	1-year :	14.28
Resists	First :	9.87	Second :	12.22
Pivot price	7.36
Supports	First :	6.05	Second :	5.04
MAs	MA(5) :	7.36	MA(20) :	7.36
	MA(100) :	9.31	MA(250) :	9.65
MACD	MACD :	-0.4	Signal :	-0.5
%K %D	K(14,3) :	92.3	D(3) :	92.3
RSI	RSI(14): 21.9
52-week	High :	12.22	Low :	6.05

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CPSR ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	-	-
Low:	-	-
Close:	-	-

As of January 13, 2022, Capstar Special Purpose Acquisition Corp. was acquired by Gelesis, Inc., in a reverse merger transaction. Capstar Special Purpose Acquisition Corp. is a blank check company. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the consumer, healthcare, and technology, media and telecommunications industries. The company was incorporated in 2020 and is based Austin, Texas.

Tue, 07 May 2024
Could The Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) Ownership Structure Tell Us Something Useful? - Yahoo Movies UK

Fri, 14 Jan 2022
Gelesis Holdings starts life after Capstar SPAC deal - The Pharma Letter

Tue, 11 Jan 2022
SPACs Bounce. Ex-Redemption Pain. And, Still no Deals - TheStreet

Mon, 10 Jan 2022
Still Waiting for a 2022 SPAC Deal as Capstar Sets Redemption Record - TheStreet

Wed, 05 Jan 2022
Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee - Business Wire

Tue, 04 Jan 2022
Still No 2022 SPAC Deal Announcements - Boardroom Alpha - TheStreet

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NYSE
Sector: Financial Services
Industry: Shell Companies
Shares Out	28 (M)
Shares Float	28 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	268 (K)
Shares Short P.Month	157 (K)

EPS	-0.44
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-1.28
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-16.73
PEG Ratio	0
Price to Book value	-5.75
Price to Sales	0
Price to Cash Flow	-186.37

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.